WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Beijing to welcome 50 giant pandas to new research baseXi Congratulates U.S.Urumqi takes measures to meet residents' need amid efforts to contain COVIDChinese FM attends reception marking 60th anniversary of ChinaPeng Liyuan Visits Vietnam National University, HanoiTurkey vows to retaliate if EU imposes new sanctionsSpotlight: U.S. authorities tell int'l students to leave U.S. if universities go onlineOver 1,500 vehicles exported via Torugart Port in Xinjiang in first two monthsU.S. gov't rescinds controversial rule on int'l students: federal judgeChinese FM Wang Yi's visit to Spain highlights bright prospects for open cooperation: spokesperson
2.3372s , 6514.796875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Worldly Web news portal